Time: 2024-11-19
A Holocene survey conduct at the University of Iowa has uncover a groundbreaking treatment for late-phase Pancreatic cancer. Dr. Joe Cullen, a professor at the university, detect that high dose of Vitamin C administer intravenously can double the overall survival time of patient. The survey show that patient who receive vitamin degree_centigrade through an four have a remarkable addition in survival from 8 calendar_month to 16 calendar_month compare to those who undergo standard chemotherapy.
The research findings print in Redox Biology foreground the success of add high-dose, intravenous vitamin C to chemotherapy for patient with late-phase metastatic pancreatic cancer. The survey, which include 34 patient, show an average overall survival of 16 calendar_month for those receive the unite treatment, compare to only 8 calendar_month for those undergo standard chemotherapy alone.
The survey conduct by Dr. Cullen and his team is not the lone evidence support the benefit of exploitation four vitamin C in Cancer treatment. earlier test on patient with glioblastoma and ongoing research on not-small cell lung cancer have show positive result as well. The team at the University of Iowa purpose to prove that integrate high-dose, four vitamin degree_centigrade in cancer treatment can significantly better result for patients.
The journey of research on high-dose, four vitamin degree_centigrade has been a hanker and challenge one, but the consequence have been transformative in the field of cancer treatment. The alone chemical chemical_reaction produce within cancer cell when expose to high degree of vitamin C through an four have make the cell more susceptible to traditional chemotherapy and radiation therapies.